CTNNB1 and colorectal cancer: Similarly, short peptide inducers of beta-catenin destruction complex condensates have been shown to reduce the levels of beta-catenin in cellular and in vivo models of colorectal cancer (Bernkopf et al., 2019; Miete et al., 2022).